Comment
. 2005 Oct;37(10):805-7; author reply 808-9.
doi: 10.1016/j.dld.2005.05.002.
Second thoughts about secondary analyses
- PMID: 16023903
- DOI: 10.1016/j.dld.2005.05.002
Item in Clipboard
Comment
Second thoughts about secondary analyses
Dig Liver Dis.
2005 Oct.
No abstract available
Comment on
-
Pharmacokinetics of pegylated interferons: what is misleading?Dig Liver Dis. 2004 Nov;36 Suppl 3:S334-9. doi: 10.1016/s1590-8658(04)80002-1. Dig Liver Dis. 2004. PMID: 15645663 Review.
-
Early virologic response with pegylated interferons.Dig Liver Dis. 2004 Nov;36 Suppl 3:S340-3. doi: 10.1016/s1590-8658(04)80003-3. Dig Liver Dis. 2004. PMID: 15645664 Review.
-
Treatment of cirrhotic patients in the pegylated interferon era.Dig Liver Dis. 2004 Nov;36 Suppl 3:S344-8. doi: 10.1016/s1590-8658(04)80004-5. Dig Liver Dis. 2004. PMID: 15645665 Review.
-
Weight-based dosing: which impact on efficacy and safety of therapy?Dig Liver Dis. 2004 Nov;36 Suppl 3:S349-53. doi: 10.1016/s1590-8658(04)80005-7. Dig Liver Dis. 2004. PMID: 15645666 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
